rcrmc-fmr.org
Effect of Rosiglitazone on the Risk of Myocardial Infarction Steven E. Nissen, M.D., and Kathy Wolski, M.P.H. Background Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus, but its From the Cleveland Clinic, Cleveland. Ad- effect on cardiovascular morbidity and mortality has not been determined. the Department of Cardiovascular Medi-cine, Cleveland Clinic, 9500 Eucl